Research and Markets: Stroke - Pipeline Review, H1 2014: Includes 62 Company Profiles

DUBLIN--()--Research and Markets ( has announced the addition of the "Stroke - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Stroke and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by our team.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned Include:

  • AGY Therapeutics, Inc.
  • APT Therapeutics, Inc.
  • Acorda Therapeutics, Inc.
  • Ampio Pharmaceuticals, Inc.
  • Anavex Life Sciences Corp.
  • Angion Biomedica Corp.
  • ArmaGen Technologies, Inc.
  • Aronora, LLC
  • AstraZeneca PLC
  • CHA Bio & Diostech Co., Ltd.
  • CardioVascular BioTherapeutics, Inc.
  • CoDa Therapeutics, Inc.
  • Covigilance sro
  • D-Pharm Ltd.
  • Diakron Pharmaceuticals, Inc.
  • Dongwha Pharm Co., Ltd.
  • Encore Therapeutics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fina Biotech
  • Generon (Shanghai) Corporation Ltd.
  • Georgia Tech Research Corporation
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • GliaMed, Inc.
  • Green Cross Corporation
  • Huons Co., Ltd.
  • InVasc Therapeutics, Inc.
  • Inbiopro Solutions Pvt. Ltd.
  • Jeil Pharmaceutical Co., Ltd.
  • Kolon Life Science, Inc.

For more information visit


Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System



Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System